Monica Coenraads’ involvement with Rett syndrome began the day her then-2-year-old daughter was diagnosed with the disorder. A year later, in 1999, she co-founded the Rett Syndrome Research Foundation (RSRF) and held the position of scientific director during the eight years of the foundation’s drive to stimulate scientific interest and research in Rett syndrome. This culminated in the groundbreaking work in 2007 that demonstrated the first global reversal of symptoms in preclinical models of the disorder. Coenraads co-founded the Rett Syndrome Research Trust (RSRT) in late 2007 to pursue the next steps from that milestone. Under her leadership at RSRF and RSRT, $36 million has been raised for research. In 2010 she co-founded the Rett Syndrome Research Trust UK, now called Reverse Rett, and currently serves as a trustee.
Monica Coenraads
Executive Director
Rett Syndrome Research Trust
Explore more from The Transmitter
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.